NEWS
COFFEE CAN PROTECT AGAINST LIVER CANCER: STUDY
It’s well known that alcohol consumption is a major risk factor for several cancers including head and neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer.
But, according to a new study funded by World Cancer Research Fund (WCRF), increased coffee consumption is associated with a lower risk of developing liver cancer and basal cell carcinoma of the skin.
‘This umbrella review confirms the evidence we have for alcohol and coffee in relation to cancer,’ said Dr Giota Mitrou, Director of Research and Innovation at WCRF. ‘Further research needs to better understand the mechanisms involved in the links between coffee and cancer as well as between alcohol and different cancer subtypes.’
CPS TO LAUNCH COMMUNITY PHARMACY WORKFORCE SURVEY 2021
In September 2021, NES Pharmacy, in conjunction with Community Pharmacy Scotland (CPS), will be co-ordinating another national community pharmacy workforce survey to gain a better understanding of team numbers and skill mix within community pharmacy in Scotland.
The information obtained will be analysed and will help to inform pharmacy workforce planning and development, ensuring we have the right workforce in place now and can take action to ensure that demand is met in the future.
The data for independent community pharmacies will be gathered via an online survey and we encourage each pharmacy to identify a single person to collate this information.
The survey has been designed to capture a snapshot of the community pharmacy workforce including pharmacists (plus those working centrally if appropriate), locum pharmacists, pre-registration trainee pharmacists, pharmacy technicians including trainees, and pharmacy support staff during the week commencing Sunday 12 September.
GPHC TAKES ACTION AGAINST PHARMACIES IN CONNECTION WITH CODEINE LINCTUS
The General Pharmaceutical Society (GPhC) has announced that, since July 2020, it has taken enforcement action against 36 pharmacy premises and a pharmacy professional following intelligence-led inspections or investigations relating to unusually high sales of codeine linctus.
Codeine linctus, classified as a Pharmacy (P) medicine under the Medicines Act 1968 and the Human Medicines Regulations 2012, is generally used for a dry cough, but is high risk because of well-known problems associated with its misuse, abuse or overuse.
The GPhC’s unannounced inspections identified that appropriate safeguards were not always in place to ensure sales were managed safely and appropriately.
At one pharmacy, the individual was found to have allowed the supply of codeine linctus without sufficient checks and safeguards and relying on questionnaires and limited clinical information. Fitness to practise investigations continue into other superintendent and responsible pharmacist implicated in similar failings.
NEW LOOK SP MAG!
Register to receive regular FREE ezines
scottishpharmacist.com
scottishpharmacist.com 39
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
